Seronegative Autoimmune Encephalitis Presenting With Severe Neuropsychiatric Symptoms in an Older Adult: A Case of Diagnostic Complexity
Open Access
- 1 January 2026
- journal article
- case report
- Published by Wiley in Case Reports in Psychiatry
- Vol. 2026 (1) , 7669338
Abstract
Autoimmune encephalitis (AE) represents a potentially reversible cause of subacute cognitive and psychiatric decline. When no autoantibodies are detected, seronegative AE remains diagnostically challenging, particularly among older adults presenting with new‐onset neuropsychiatric symptoms. This report describes an older adult with recurrent episodes of confusion, aphasia, and psychosis whose diagnostic studies—including magnetic resonance imaging (MRI) and cerebrospinal fluid (CSF) analysis—were unremarkable. The individual had previously demonstrated substantial improvement after corticosteroid therapy and was again treated empirically with immunotherapy following psychiatric consultation. This case highlights the importance of maintaining a high index of suspicion for AE when standard serologic markers are absent and underscores the collaborative role of psychiatry and neurology in evaluating rapidly progressive cognitive and behavioral syndromes, which may present initially as primary psychiatric illness. Early consideration of autoimmune etiologies and prompt initiation of immunotherapy can significantly improve outcomes in patients with otherwise unexplained, rapidly progressive cognitive or behavioral syndromes.Keywords
This publication has 11 references indexed in Scilit:
- Possible Tacrolimus-associated seronegative Autoimmune Encephalitis presenting with subacute cognitive impairment and disorientation - case reportFrontiers in Medicine, 2025
- Prediction model for severe autoimmune encephalitis: a tool for risk assessment and individualized treatment guidanceFrontiers in Neurology, 2025
- The Neuropsychiatric Checklist for Autoimmune Psychosis: A Narrative ReviewBiological Psychiatry, 2025
- Psychiatric manifestations of encephalitisAnnals of Clinical and Translational Neurology, 2025
- Analysis of characteristics of movement disorders in patients with anti-N-methyl-D-aspartate receptor encephalitisFrontiers in Neurology, 2024
- Movement disorders in cell surface antibody mediated autoimmune encephalitis: a meta-analysisFrontiers in Neurology, 2023
- Seronegative autoimmune encephalitis: exploring the unknownBrain, 2022
- Electroconvulsive therapy for anti-N-methyl-d-aspartate (NMDA) receptor encephalitis: A systematic review of casesBrain Stimulation, 2019
- A clinical approach to diagnosis of autoimmune encephalitisThe Lancet Neurology, 2016
- Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort studyThe Lancet Neurology, 2013